This inventor holds 3 USPTO granted patents. Top assignee: Dupont Pharmaceuticals Company. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: The Innovations of William Eric Frietze
Introduction
William Eric Frietze is a notable inventor based in Kennett Square, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 3 patents, Frietze's work has garnered attention in the scientific community.
Latest Patents
Among his latest patents, Frietze has developed isoxazolo[4,5-D]pyrimidines as CRF antagonists. This invention describes novel isoxazolo[1,5-a]pyrimidines of a specific formula, which have potential applications in treating various conditions. Additionally, he has worked on triazinones and derivatives thereof, which also serve as corticotropin-releasing factor (CRF) antagonists of Formula (I).
Career Highlights
Frietze is currently employed at DuPont Pharmaceuticals Company, where he continues to innovate and contribute to the field. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Throughout his career, Frietze has collaborated with esteemed colleagues, including Argyrios Georgios Arvanitis and Richard Eric Olson. These partnerships have enhanced the scope and impact of his research.
Conclusion
William Eric Frietze's contributions to pharmaceutical innovations highlight his expertise and dedication to advancing medical science. His patents reflect a commitment to developing new therapeutic options for various health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile